Doctor of Philosophy (PhD), 1983
Guy’s Hospital Medical School, University of London, UK
Bachelor of Science Honours (BSc Hons) and Associate of the Royal College of Science (ARCSc), 1979
Imperial College of Science and Technology, University of London, UK
Dr Anthi Drousiotou was born in Nicosia, Cyprus. After graduating from the English School, she went to the UK for her university studies. She obtained a BSc degree in Biochemistry from Imperial College, University of London and then went on to do a PhD degree at Guy’s Hospital Medical School, University of London, on a studentship from the Muscular Dystrophy Group of Great Britain. Upon her return to Cyprus in 1984, she worked for five years in the Biochemistry and Haematology departments of Limassol General Hospital. From 1989 to 2003 she worked at the Thalassaemia Centre in Nicosia where she was responsible for the biosynthetic studies for β- and α-thalassaemia, including prenatal diagnosis, and for the monitoring of the iron chelation therapy of thalassaemia patients. During the same period she became actively involved with the Cyprus Institute of Neurology & Genetics. After a number of training fellowships in well-established laboratories of Biochemical Genetics abroad, she set up the Department of Biochemical Genetics at the CING to act as a reference centre in Cyprus for the laboratory investigation of inherited metabolic disorders. Her research work focused mainly on the epidemiology and molecular characterization of inborn errors of metabolism in Cyprus, including Sandhoff’s disease, GM1 gangliosidosis, MSUD, ethylmalonic encephalopathy, phenylketonuria, galactosaemia and others. She has supervised several PhD and MSc students.
Dr Drousiotou has served as a member of the Board of Directors of several professional societies including the Cyprus Society of Human Genetics and the Cyprus Society of Sciences. She is currently a member of the Board of Trustees of ERNDIM (European Research Network for evaluation and improvement of screening, Diagnosis and treatment of Inherited disorders of Metabolism) and National Representative for Cyprus in the EuroGentest Project (Biochemical Genetics). She is a member of the National Steering Committee for Rare Disorders and the National Steering Committee for Neonatal Screening. She is also the Secretary of the National Register Committee for Specialists in Clinical Chemistry and Laboratory Medicine (NRC-CCLM). She has been involved in the organization of many conferences, seminars and workshops.